Galectin-3 levels are elevated following nintedanib treatment

• Prif Awduron: Gali Epstein Shochet (Awdur), Alon Pomerantz (Awdur), David Shitrit (Awdur), Becky Bardenstein-Wald (Awdur), Kjetil Ask (Awdur), Mark Surber (Awdur), Noa Rabinowicz (Awdur), Yair Levy (Awdur), Sydney Benchetrit (Awdur), Evgeny Edelstein (Awdur), Tali Zitman-Gal (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: SAGE Publishing, 2020-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background and Aims: Idiopathic pulmonary fibrosis (IPF) is a common and severe form of pulmonary fibrosis. Nintedanib, a triple angiokinase inhibitor, is approved for treating IPF. Galectin 3 (Gal-3) activates a variety of profibrotic processes. Currently, the Gal-3 inhibitor TD139 is being tested...